Microbio Co., Ltd. (TPEX:4128)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
14.80
-0.30 (-1.99%)
Aug 19, 2026, 9:42 AM CST

Microbio Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,9651,8941,7231,5911,7221,782
Revenue Growth
8.41%9.94%8.26%-7.58%-3.38%11.28%
Gross Profit
778.39753.46676.08603.88691.3739.37
Operating Income
-467.59-407.11-451.42-506.47-110.31-1,163
Net Income
523.23-757.75-1,101-1,180211.249.42
Earnings Per Share
0.88-1.29-1.87-2.010.360.09
EPS Growth
----316.73%-92.89%

Revenue by Segment

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Health and vitality food
1,7771,6381,5221,6601,724
Research and development of new medicine
116.9585.0869.1361.6357.82
Total
1,8941,7231,5911,7221,782

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2,8372,6302,5523,6374,0784,032
Total Debt
708.04667.2615.73619.16487.82517.57
Net Cash (Debt)
2,1291,9631,9373,0183,5903,515
Net Cash Growth
10.96%1.35%-35.82%-15.95%2.16%-4.17%
Net Cash Per Share
3.613.343.295.136.116.13

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-193.485.27529.9-118.75141.5753.98
Capital Expenditures
-49.15-60.79-22.58-44.78-38.88-87.22
Free Cash Flow
-242.5524.49507.32-163.53102.69-33.24
Free Cash Flow Growth
--95.17%----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
39.60%39.78%39.24%37.95%40.15%41.49%
Operating Margin
-23.79%-21.49%-26.20%-31.83%-6.41%-65.25%
Pretax Margin
13.40%-50.24%-74.20%-86.58%8.82%-13.01%
Profit Margin
26.62%-40.01%-63.89%-74.14%12.27%2.77%
FCF Margin
-12.34%1.29%29.45%-10.28%5.96%-1.86%

Dividends

Fiscal YearFY 2022FY 2021
Period EndingDec '22 Dec '21
Dividend Per Share
0.0350.032
Dividend Per Share Growth
9.43%-
Dividend Yield
0.06%0.06%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
17.07---150.52641.61
Forward PE
-59.4659.4659.4659.4659.46
P/FCF Ratio
-444.4038.26-309.59-
PS Ratio
4.525.7511.2717.7818.4617.79